Growth hormone deficiency: Growth hormone tests and growth hormone measurements

Growth Hormone Therapy in Pediatrics-20 Years of KIGS

Volumn , Issue , 2007, Pages 38-46

  Rose, Susan R ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53949090076     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000101521     Document Type: Chapter

References (59)

1. Juul A: Determination of insulin-like growth factor I in children: normal values and clinical use. Horm Res 2001; 55(suppl 2):94-99.
2. Juul A, Skakkebaek NE: Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. J Pediatr 1997; 130: 197-204.
3. Nunez SB, Municchi G, Rose SR: Insulin-like growth factor-1 and insulinlike growth factor binding protein-3 compared with stimulated and overnight growth hormone in short children. J Clin Endocrinol Metab 1996; 81: 1927-1932.
4. Maghnie M, Ghirardello S, Genovese E: Magnetic resonance imaging of the hypothalamus-pituitary unit in children suspected of hypopituitarism: who, how and when to investigate. J Endocrinol Invest 2004; 27: 496-509.
5. Wilson T, Rose SR, Cohen P, Rogol AD, the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society: Update of guidelines for the use of growth hormone in children. J Pediatr 2003; 143: 415-421.
6. Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F: Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 1996; 81: 3323-3327.
7. Rose SR: Neuroendocrine basis for insufficient growth hormone and its assessment; in Savage MO, Bourguignon JP, Grossman AB (eds): Frontiers in Paediatric Neuroendocrinology. Oxford, Blackwell, 1994, pp 149-155.
8. de Gennaro Colonna V, Cella SG, Locatelli V, Loche S, Ghigo E, Cocchi D, Muller EE: Neuroendocrine control of growth hormone secretion. Acta Paediatr Scand Suppl 1989; 349: 87-92.
9. Cara JF, Rosenfeld RG, Furlanetto RW: A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child 1987; 141: 562-564.
10. Veldhuis JD: Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender. Growth Horm IGF Res 1998; 8(suppl B):49-59.
11. Aimaretti G, Baffoni C, Bellone S, Di Vito L, Corneli G, Arvat E, Benso L, Camanni F, Ghigo E: Retesting young adults with childhood-onset growth hormone (GH) deficiency with GHreleasing hormone-plus-arginine test. J Clin Endocrinol Metab 2000; 85: 3693-3699.
12. Loche S, Bizzarri C, Maghnie M, Faedda A, Tzialla C, Autelli M, Casini MR, Cappa M: Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency. J Pediatr 2002; 140: 445-449.
13. Chatelain P, Bouillat B, Cohen R, Sassolas G, Souberbielle JC, Ruitton A, Joly MO, Job JC: Assay of growth hormone levels in human plasma using commercial kits: analysis of some factors influencing the results. Acta Paediatr Scand Suppl 1990; 370: 56-61.
14. Celniker AC, Chen AB, Wert RM Jr, Sherman BM: Variability in the quantitation of circulating growth hormone using commercial immunoassays. J Clin Endocrinol Metab 1989; 68: 469-476.
15. Cooke NE, Ray J, Watson MA, Estes PA, Kuo BA, Liebhaber SA: Human growth hormone gene and the highly homologous growth hormone variant gene display different splicing patterns. J Clin Invest 1988; 82: 270-275.
16. Tanaka T, Tachibana K, Shimatsu A, Katsumata N, Tsushima T, Hizuka N, Fujieda K, Yokoya S, Irie M: A nationwide attempt to standardize growth hormone assays. Horm Res 2005; 64(suppl 2):6-11.
17. Juul A, Bernasconi S, Clayton PE, Kiess W, DeMuinck-Keizer Schrama S, Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology: European audit of current practices in diagnosis and treatment of childhood growth hormone deficiency. Horm Res 2002; 58: 233-241.
18. Rose SR, Municchi G, Barnes KM, Kamp GA, Uriarte MM, Ross JL, Cassorla F, Cutler GB Jr: Spontaneous growth hormone secretion increases during puberty in normal girls and boys. J Clin Endocrinol Metab 1991; 73: 428-435.
19. Tannenbaum GS: Neuroendocrine control of growth hormone secretion. Acta Paediatr Scand Suppl 1991; 372: 5-16.
20. Koutkia P, Canavan B, Breu J, Johnson ML, Grinspoon SK: Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men. Am J Physiol Endocrinol Metab 2004; 287:E506-E512.
21. Rose SR, Municchi G, Barnes K, Cutler GB: Overnight growth hormone concentrations are usually normal in pubertal children with idiopathic short stature-a clinical research center study. J Clin Endocrinol Metab 1996; 81:1063-1068.
22. Hartman ML, Veldhuis JD, Thorner MO: Normal control of growth hormone secretion. Horm Res 1993; 40: 37-47.
23. Sartorio A, De Nicolao G, Liberati D: An improved computational method to assess pituitary responsiveness to secretagogue stimuli. Eur J Endocrinol 2002; 147: 323-332.
24. Hartman ML, Faria AC, Vance ML, Johnson ML, Thorner MO, Veldhuis JD: Temporal structure of in vivo growth hormone secretory events in humans. Am J Physiol 1991; 260: 101-110.
25. Veldhuis JD, Anderson SM, Shah N, Bray M, Vick T, Gentili A, Mulligan T, Johnson ML, Weltman A, Evans WS, Iranmanesh A: Neurophysiological regulation and target-tissue impact of the pulsatile mode of growth hormone secretion in the human. Growth Horm IGF Res 2001; 11(suppl A):25-37.
26. Hindmarsh PC, Brain CE, Robinson IC, Matthews DR, Brook CG: The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man. Clin Endocrinol (Oxf) 1991; 35: 353-360.
27. Shulman DI, Bercu BB: Evaluation of growth hormone secretion: provocative testing vs endogenous 24-hour growth hormone profile. Acta Paediatr Scand Suppl 1987; 337: 61-71.
28. Rose SR, Ross JL, Uriarte M, Barnes KM, Cassorla FG, Cutler GB Jr: The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. N Engl J Med 1988; 319: 201-208.
29. Tanaka T: Growth hormone secretion and the therapeutic effects of human growth hormone: first Japanese results of the Kabi Pharmacia International Growth Study/International Cooperative Growth Study. Acta Paediatr Scand Suppl 1991; 379: 126-135.
30. Maghnie M, Cavigioli F, Tinelli C, Autelli M, Arico M, Aimaretti G, Ghigo E: GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset. J Clin Endocrinol Metab 2002; 87: 2740-2744.
31. Petersenn S, Jung R, Beil FU: Diagnosis of growth hormone deficiency in adults by testing with GHRP-6 alone or in combination with GHRH: comparison with the insulin tolerance test. Eur J Endocrinol 2002; 146: 667-672.
32. Vierhapper H, Nardi A, Bieglmayer C: The use of the pyridostigmine growth hormone-releasing hormone stimulation test to detect growth hormone deficiency in patients with pituitary adenomas. Metabolism 2002; 51: 34-37.
33. Biller BMK, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman MK: Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002; 67: 1186-1189.
34. Ham JN, Ginsberg JP, Hendell CD, Moshang T: Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy. Clin Endocrinol 2005; 62: 628-632.
35. Donaubauer J, Kiess W, Kratzsch J, Nowak T, Steinkamp H, Willgerodt H, Keller E: Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency. Clin Endocrinol (Oxf) 2003; 58: 456-463.
36. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO: Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987; 64: 51-58.
37. Bussieres L, Souberbielle JC, Pinto G, Adan L, Noel M, Brauner R: The use of insulin-like growth factor 1 reference values for the diagnosis of growth hormone deficiency in prepubertal children. Clin Endocrinol 2000; 52: 735-739.
38. Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E, Camanni F, Aimaretti G: The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 2005; 15: 257-264.
39. Kasa-Vubu JZ, Barkan A, Olton P, Meckmongkol T, Carlson NE, Foster CM: Incomplete modified fast in obese early pubertal girls leads to an increase in 24-hour growth hormone concentration and a lessening of the circadian pattern in leptin. J Clin Endocrinol Metab 2002; 87: 1885-1893.
40. Maghnie M, Valtorta A, Moretta A, Larizza D, Preti P, Palladini G, Calcante S, Severi F: Diagnosing growth hormone deficiency: the value of shortterm hypocaloric diet. J Clin Endocrinol Metab 1993; 77: 1372-1378.
41. Rose SR, Burstein S, Burghen GA, Pitukcheewanont P, Shope S, Hodnicak V: Caloric restriction for 24 hours increases mean night growth hormone. J Pediatr Endocrinol Metab 1999; 12: 175-183.
42. Aimaretti G, Ambrosio MR, Di Somma C, Gasperi M, Cannavo S, Scaroni C, De Marinis L, Baldelli R, Bona G, Giordano G, Ghigo E: Hypopituitarism induced by traumatic brain injury in the transition phase. J Endocrinol Invest 2005; 28: 984-989.
43. Agha A, Phillips J, O'Kelly P, Tormey W, Thompson CJ: The natural history of post-traumatic hypopituitarism: implications for assessment and treatment. Am J Med 2005; 118: 1416.
44. Reifschneider K, Blum SD, Weiss M, Rose SR: Endocrinopathies after head injury in children. Abstr, 88th Annu Meet Endocr Soc, Boston , 2006.
45. Rose SR: Endocrinopathies in childhood cancer survivors. Endocrinologist 2003; 13: 488-495.
46. Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gattamaneni HR, Brennan BM, Shalet SM: Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J Clin Endocrinol Metab 2003; 88: 3682-3689.
47. Adan L, Trivin C, Sainte-Rose C, Zucker JM, Hartmann O, Brauner R: GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults. J Clin Endocrinol Metab 2001; 86: 5245-5251.
48. Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H, Hudson MM, Kun L, Heideman RL: Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 1999; 84: 4472-4479.
49. Rose SR, Danish RK, Kearney NS, Schreiber RE, Lustig RH, Burghen GA, Hudson MM: ACTH deficiency in childhood cancer survivors. Pediatr Blood Cancer 2005; 45: 808-813.
50. Merchant TE, Williams T, Smith JM, Rose SR, Danish RK, Burghen GA, Kun LE, Lustig RH: Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function. Int J Radiat Oncol Biol Phys 2002; 54: 45-50.
51. Darzy KH, Pezzoli SS, Thorner MO, Shalet SM: The dynamics of growth hormone (GH) secretion in adult cancer survivors with severe GH deficiency acquired after brain irradiation in childhood for nonpituitary brain tumors: evidence for preserved pulsatility and diurnal variation with increased secretory disorderliness. J Clin Endocrinol Metab 2005; 90: 2794-2803.
52. GH Research Society: Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000; 85: 3990-3993.
53. Gleeson HK, Gattamaneni HR, Smethurst L, Brennan BM, Shalet SM: Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy. J Clin Endocrinol Metab 2004; 89: 662-666.
54. Darzy KH, Aimaretti G, Wieringa G, Rao Gattamaneni H, Ghigo E, Shalet SM: The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the postirradiation time interval. J Clin Endocrinol Metab 2003; 88: 95-102.
55. Lissett CA, Saleem S, Rahim A, Brennan BM, Shalet SM: The impact of irradiation on growth hormone responsiveness to provocative agents is stimulus dependent: results in 161 individuals with radiation damage to the somatotropic axis. J Clin Endocrinol Metab 2001; 86: 663-668.
56. Leung W, Rose SR, Zhou Y, Hancock ML, Burstein S, Schriock EA, Lustig R, Danish RK, Evans WE, Hudson MM, Pui CH: Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 2002; 20: 2959-2964.
57. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL: Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002; 87: 3136-3141.
58. Swerdlow AJ, Reddingius RE, Higgins CD, Spoudeas HA, Phipps K, Qiao Z, Ryder WD, Brada M, Hayward RD, Brook CG, Hindmarsh PC, Shalet SM: Growth hormone treatment of children with brain tumours and risk of tumour recurrence. J Clin Endocrinol Metab 2000; 85: 4444-4449.
59. Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robison LL, Sklar CA: Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 2006;91: 3494-3498.